Vaccines, blood, antisera, toxins and cultures in   France

Exports In 2022, France exported $10.2B in Vaccines, blood, antisera, toxins and cultures, making it the 8th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 11th most exported product in France. The main destination of Vaccines, blood, antisera, toxins and cultures exports from France are: Belgium ($2.72B), Germany ($1.78B), China ($477M), Italy ($422M), and United States ($349M).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of France between 2021 and 2022 were Belgium ($366M), Germany ($181M), and Switzerland ($96.8M).

Imports In 2022, France imported $12.1B in Vaccines, blood, antisera, toxins and cultures, becoming the 9th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 8th most imported product in France. France imports Vaccines, blood, antisera, toxins and cultures primarily from: Belgium ($2.59B), Switzerland ($2.02B), Germany ($2B), Netherlands ($1.54B), and Ireland ($1.11B).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for France between 2021 and 2022 were Belgium ($662M), Ireland ($356M), and United Kingdom ($202M).